3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
37
Head & Neck
4
Thoracic
2
Dermatologic
2
Breast
2
Sarcoma
1
Other solid neoplasm
1
NET
1
Gynecologic
1
Genitourinary
1
Endocrine
1
CNS
1
Conditions
Neuroendocrine Tumors
52
Gastro-enteropancreatic neuroendocrine tumor
10
Carcinoma, Neuroendocrine
8
Small Cell Lung Carcinoma
6
Adenoma, Islet Cell
6
Colorectal Neoplasms
5
Carcinoma, Merkel Cell
4
Pancreatic Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Hepatocellular
3
Carcinoid Tumor
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Salivary Gland Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Neoplasms, Unknown Primary
2
Neoplasms
2
Microsatellite Instability
2
Mesothelioma
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Medullary
2
Brain Neoplasms
2
Biliary Tract Neoplasms
2
Vulvar Neoplasms
1
Vipoma
1
Urinary Bladder Neoplasms
1
Interventions
Poly(ADP-ribose) Polymerase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Squamous Cell Carcinoma
×
NET
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled